Skip to contentUniversity of Michigan Health System - link
Department of Internal Medicine - link
INFECTIOUS DISEASES
search this site
 

About Us



Info for Patients




Referring Physicians




Our Faculty




Education & Research



HIV/AIDS Treatment Program




More News




Internal Resources




Internal Medicine Divisions

 
Dr. Nirit Mor-Vaknin

Description of Research: Nirit Mor-Vaknin

Autoimmune diseases arise when the immune system turns its antimicrobial defenses upon normal components of the body (self). While the cause of autoimmune disease is not clear, autoimmune diseases affect 5% of the world's population, and there is evidence of increasing disease incidence in children. Our studies focus on the potential new role of nuclear proteins, such as DEK and intracellular intermediate filaments, such as vimentin, in the innate immunity response to bacterial infection and the development of autoimmune diseases.

We recently discovered that the nuclear protein DEK and the cytoskeleton protein vimentin are both actively secreted by human macrophages. Macrophages can secrete many proteins as part of their immune function; proteins such as cytokines, chemokines and proteases. However, the secretion of nuclear proteins or cytoskeleton proteins by macrophages is unusual and may indicate a unique immunological function for both DEK and vimentin.

The intermediate filament vimentin, which is particularly abundant in human macrophages, has always been regarded as an intracellular structural protein. However, vimentin secretion via activated macrophages suggests a whole set of different functions for vimentin. Indeed, we have shown that extracellular vimentin is involved in the generation of oxidative metabolites and the killing of Escherichia coli (E. coli), two important functions of activated macrophages. Vimentin knockout mice also show a lesser rate of mortality following intraperitoneal challenge with lethal doses of E. coli, as compared to wild-type mice. Further, treatment with anti-vimentin antibodies protects mice from intraperitoneal infection with lethal doses of E. coli. Our findings strongly suggest an important role for vimentin as part of the immune response to bacterial inflammation and may lead to the development of new therapeutic targets for the treatment of bacterial inflammation and sepsis.

We have also demonstrated that cellular activation and differentiation of macrophages cause the secretion of DEK, previously considered to be a strictly nuclear protein. The secretion of the nuclear DEK protein is stimulated by Interleukin-8 and inhibited by certain immunosuppressive agents like dexamethasone and cyclosporin A. DEK is secreted into the extracellular space of activated macrophages and synovial mononuclear cells via exosome-like vesicles that are thought to be capable of antigen presentation, as well as by another unknown pathway. Moreover, a high level of DEK protein is detected in synovial fluids from patients with juvenile arthritis. Additionally, cell migration assays indicate that recombinant DEK acts as a lymphocyte, neutrophil, and perhaps endothelial cell chemoattractant via the CXCR1/CXCR2 receptors, suggesting that DEK amplifies the local immune response in the joint space. In view of that above and recent reports of antibody to DEK being found in some children with juvenile idiopathic arthritis (JIA) and related diseases, studying the role of DEK in the pathogenesis of inflammation and autoimmune disease holds great promise for improving our knowledge of how these conditions begin, and how they might be treated more effectively.

Recent Publications:

Mor-Vaknin N., Punturieri A., Sitwala K., Faulkner N., Legendre M., Khodadoust M., Ferdinand K,. Ruth H.J., Koch A., Glass D., Petruzzelli L., Adams S.B., and Markovitz D.M. The DEK nuclear autoantigen is a secreted chemotactic factor. Mol Cell Biol. (2006) Dec;26(24):9484-96.

Bargagna-Mohan P., Hamza A., Kim Y.E., Khuan Abby Ho Y., Mor-Vaknin N., Wendschlag N., Liu J., Evans R.M., Markovitz D.M., Zhan C.G., Kim K.B., Mohan R. The tumor inhibitor and antiangiogenic agent Withaferin A targets the intermediate filament protein vimentin. Chem Biol. (2007) Jun;14(6):623-34.

Kappes F, Fahrer J, Khodadoust MS, Tabbert A, Strasser C, Mor-Vaknin N, Moreno-Villanueva M, Burkle A, Markovitz DM, Ferrando-May E. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress. Molec Cell Biol 28 (10): 3245-3257, 2008.

McDowell KL, Begley LA, Mor-Vaknin N, Markovitz DM, Macoska JA. Leukocytic promotion of prostate cellular proliferation. The Prostate (published online October 28, 2009).

Mor-Vaknin N, Kappes F, Dick AE, Legendre M, Damoc C, Teitz-Tennenbaum S, Kwok R, Ferrando-May E, Adams BS, Markovitz DM. DEK in the Synovium of Patients With Juvenile Idiopathic Arthritis Characterization of DEK Antibodies and Posttranslational Modification of the DEK Autoantigen. Arthritis Rheumatism 63 (2): 556-567, 2011.

 
   
   

U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright Regents of the University of Michigan
Template developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index